Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition: Opioid Use Disorder Interventions: Drug: Buprenorphine/naloxone; Drug: Hydromorphone Sponsors: University of British Columbia; Vancouver Coastal Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2020 Category: Research Source Type: clinical trials
Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
Conditions: Opioid-use Disorder; Suicidal Ideation Interventions: Drug: Buprenorphine/Naloxone 8/2 milligram (mg) Sublingual Film; Drug: Morphine Sulfate 30 mg Sponsor: New York State Psychiatric Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2020 Category: Research Source Type: clinical trials
Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition: Opioid Use Disorder Interventions: Drug: Buprenorphine/naloxone; Drug: Hydromorphone Sponsors: University of British Columbia; Vancouver Coastal Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2020 Category: Research Source Type: clinical trials
Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
Conditions: Opioid-use Disorder; Suicidal Ideation Interventions: Drug: Buprenorphine/Naloxone 8/2 milligram (mg) Sublingual Film; Drug: Morphine Sulfate 30 mg Sponsor: New York State Psychiatric Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2020 Category: Research Source Type: clinical trials
Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
Condition: Opioid Use Disorder Interventions: Drug: Buprenorphine/naloxone; Drug: Hydromorphone Sponsors: University of British Columbia; Vancouver Coastal Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2020 Category: Research Source Type: clinical trials
A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Conditions: Opioid-use Disorder; Opioid Use Disorder, Mild Interventions: Drug: Buprenorphine; Drug: Buprenorphine/naloxone Sponsor: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2019 Category: Research Source Type: clinical trials
